Welcome to the Office of the Principal Scientific Adviser
India has had a Principal Scientific Adviser (PSA) since 1999. Dr. A. P. J. Abdul Kalam was the first PSA from 1999—2002 and Dr. R. Chidambaram from 2008-2018. Professor K. VijayRaghavan succeeded Dr. Chidambaram on 3 April 2018.
To translate this vision into strategy and action, the Prime Minister has constituted the Prime Minister’s Science, Technology and Innovation Advisory Council (PM’s STIAC) (Give Link). The Principal Scientific Adviser is Chair of the PM’s STIAC.
Our terms of reference are extensive and demanding. These are listed below:
- Synergizing S&T covering fundamental to applied research in collaboration with multiple stake holders both in central and state governments
- Enabling future preparedness in emerging domains of science and technology
- Formulating and coordinating major inter-ministerial S&T missions
- Providing an enabling ecosystem for technology led innovations and techno-entrepreneurship
- Driving innovation and technology delivery towards solving socio-economic challenges for sustainable growth
- Fostering effective public-private linkages for driving research and innovation
- Developing innovation clusters with multiple stakeholders including academia, industry and government
- Skilling in current and futuristic technologies.
PM-STIAC Constitution (click here)
In discharging the above duties, the PSA’s Office has promoted cross-sectoral synergy projects in various science and technology domains. These include policy interventions, small but catalytic support to R&D projects that do not fall into the business domain of any single department and specifically in areas in which there are significant gaps that needs to be addressed. To harness innovation and effective technology commercialization, the PSA’s office has launched a special initiative called ‘Accelerating Growth for New India innovations’ (AGNIi). This is aimed at technology upscaling and deployment for deriving economic value or societal benefit from knowledge generated through research investments in R&D.